Cargando…
Clinical benefits of systemic amoxicillin/metronidazole may depend on periodontitis severity and patients' age: An exploratory sub‐analysis of the ABPARO trial
AIM: The aim was to identify benefit thresholds for clinical variables. We hypothesize, if variables fall below or exceed these threshold levels, systemic amoxicillin/metronidazole may contribute to reducing progression of periodontitis. MATERIAL & METHODS: This is an explorative per‐protocol co...
Autores principales: | Eickholz, Peter, Koch, Raphael, Kocher, Thomas, Hoffmann, Thomas, Kim, Ti‐Sun, Meyle, Joerg, Kaner, Doğan, Schlagenhauf, Ulrich, Harmsen, Dag, Harks, Inga, Ehmke, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594242/ https://www.ncbi.nlm.nih.gov/pubmed/30825384 http://dx.doi.org/10.1111/jcpe.13096 |
Ejemplares similares
-
Is progression of periodontitis relevantly influenced by systemic antibiotics? A clinical randomized trial
por: Harks, Inga, et al.
Publicado: (2015) -
Significant Short-Term Shifts in the Microbiomes of Smokers With Periodontitis After Periodontal Therapy With Amoxicillin & Metronidazole as Revealed by 16S rDNA Amplicon Next Generation Sequencing
por: Hagenfeld, Daniel, et al.
Publicado: (2020) -
Do we treat our patients or rather periodontal microbes with adjunctive antibiotics in periodontal therapy? A 16S rDNA microbial community analysis
por: Hagenfeld, Daniel, et al.
Publicado: (2018) -
Long‐term impact of powered toothbrush on oral health: 11‐year cohort study
por: Pitchika, Vinay, et al.
Publicado: (2019) -
Regular consumption of Lactobacillus reuteri‐containing lozenges reduces pregnancy gingivitis: an RCT
por: Schlagenhauf, Ulrich, et al.
Publicado: (2016)